Bumper Offer - Urjas oil Just @ Rs. 1
Vominil is a prescription medicine. It is primarily used for the treatment of Nausea and Vomiting. Vominil also has some secondary and off-label uses. These are listed below.
The correct dosage of Vominil depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Vominil are Diarrhoea, Drowsiness, Insomnia. Some other side effects of Vominil have been listed ahead. Usually, these side effects of Vominil go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Vominil is Mild for pregnant women and Moderate for women who are breastfeeding. It is important to know if Vominil has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Vominil related warnings section.
Vominil is contraindicated in people with pre-existing medical conditions like Gastrointestinal Bleeding as it can result in adverse effects. Other contraindications of Vominil have been discussed in the sections ahead.
Drug reaction of Vominil with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Vominil, it is important to know that it is not safe while driving, and is not habit-forming.
Vominil is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Vominil is used -
Severe
Moderate
Common
Unknown
Is the use of Vominil safe for pregnant women?
Vominil has little to no side effects in pregnant women.
Is the use of Vominil safe during breastfeeding?
Breastfeeding women may feel side effects of Vominil. If you see any side effects, stop taking Vominil immediately and talk to your doctor. Take Vominil again, only after your doctor's advice.
What is the effect of Vominil on the Kidneys?
Vominil may have mild side effects on the kidneys.
What is the effect of Vominil on the Liver?
Side effects of Vominil rarely affect the liver.
What is the effect of Vominil on the Heart?
Side effects of Vominil rarely affect the heart.
Vominil should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Mild
If you are suffering from any of the following diseases, you should not take Vominil unless your doctor advises you to do so -
Is this Vominil habit forming or addictive?
Vominil does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Vominil can make you feel drowsy.
Is it safe?
Vominil should be used only after doctor's advice.
Is it able to treat mental disorders?
Vominil is unable to treat or cure mental disorders.
Interaction between Food and Vominil
Taking Vominil with food does not harm your health.
Interaction between Alcohol and Vominil
Consult your doctor before consuming alcohol while taking Vominil as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Reglan® (metoclopramide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 664-667
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Reglan® (metoclopramide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 664-667
